P21
Preclinical ResearchAlso known as: Humanin analogue P21
Educational Content Only
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The FDA has not evaluated many of the peptides discussed here. Always consult a licensed healthcare provider before making any health decisions.
P21 is a short synthetic peptide derived from humanin with modifications intended to enhance potency and stability. Research has examined its potential roles in neuroprotection, cognitive function, and cellular survival signaling, particularly in the context of Alzheimer's disease models and age-related cognitive decline.
The following areas have been examined in research contexts. This does not constitute medical advice or imply proven efficacy in humans.
- Cognitive Enhancement
- Anti-Aging & Longevity
P21 is proposed to act through humanin receptor pathways including CNTFR/WSX-1/gp130 tripartite receptor complex signaling, modulating neuronal survival, insulin signaling, and synaptic function in preclinical models.
Studied primarily in animal models. Human safety data is not available. Not FDA-approved.
Want to learn more?
Ask Research Chat about P21Half-Life
Not established in humans
Administration
subcutaneous injection, intranasal (in research)
Legal Status (US)
Research chemical. Not FDA-approved for human use.
209 indexed research passages
Related Peptides
Oxytocin is a nine-amino acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary, studied extensively for its roles in social bonding, trust, maternal behavior, uterine contraction, and lactation. It is FDA-approved for obstetric indications and has been extensively studied in clinical contexts including autism spectrum disorder and social anxiety.
Tropisetron is a 5-HT3 receptor antagonist and alpha7 nicotinic acetylcholine receptor agonist approved in various countries for chemotherapy-induced nausea. Research has also examined its potential roles in pain management, fibromyalgia, and cognitive enhancement through its dual receptor pharmacology.
Lemairamin is a plant-derived alkaloid (isolated as WGX-50 from Evodia lepta) studied in the context of neuroprotection and neurological aging. Research in animal models has examined its potential to protect neurons from amyloid-beta toxicity and oxidative stress, with interest in Alzheimer's disease research.
9-ME-BC is a synthetic β-carboline alkaloid with structural similarity to naturally occurring harman compounds. Research in animal models has examined its potential neuroprotective, dopaminergic, and pro-cognitive properties, with particular interest in its ability to promote neurogenesis and dendritic growth in dopaminergic neurons.